论文部分内容阅读
由我院骨痨敌研究组研制的抗痨新药“骨痨敌Ⅰ”于八五年二月八日在咸阳通过鉴定。骨关节结核和淋巴结核,曾被人们视为沉疴痼疾。我院“骨痨敌”研究组,从一九六九年开始,完全用中药制成一种有效的抗痨药物“骨痨敌Ⅰ”,经用于临床治疗各型骨关节结核,有效率高达95%以上。对颈淋巴等部位的结核亦有明显的疗效。通过大量的基础实验,证明该药不仅具有抗结核杆菌和提高机体细胞免疫的功能,而且无不良反应,为中药治疗结核病开创了新路。
The new bone-smashing enemy “I” developed by the research team of the bone destruction and enemies of our hospital passed the appraisal in Xianyang on February 8, 1995. Bone and joint tuberculosis and lymphatic tuberculosis have been considered as sickness. The Research Group of Bone Loss Enforcement in our hospital started from 1969, using Chinese medicine to make an effective anti-tuberculosis drug “Bone Scorpion Enemy I”. It is used for the clinical treatment of various types of bone and joint tuberculosis. Up to 95%. It is also effective in the treatment of tuberculosis in the cervical lymph nodes. Through a large number of basic experiments, it has been proved that the drug not only has anti-Mycobacterium tuberculosis and improves the function of cellular immunity, but also has no adverse reactions. It has created a new path for the treatment of tuberculosis by Chinese medicine.